| Dec, 19 | Roche and Beaufour Ipsen to jointly develop and market Beaufour Ipsen's novel anti-cancer drugs more.. |
| Dec, 11 | Markus Altwegg to retire in spring 2003 more.. |
| Dec, 5 | Roche receives FDA clearance for the Cobas AmpliScreen System more.. |
| Nov, 20 | Roche receives FDA clearance for Elecsys proBNP assay - First automated blood test to aid in the diagnosis of congestive heart failure more.. |
| Nov, 18 | Roche to acquire promising portfolio of cancer drugs from Antisoma more.. |
| Nov, 12 | Roche Scientists Exceed Expectations of Genetic Discoveries more.. |
| Oct, 28 | MabThera/Rituxan effective in treatment of Rheumatoid Arthritis more.. |
| Oct, 10 | Roche's Pharmaceuticals and Diagnostics Divisions on Course more.. |
| Oct, 3 | Roche files supplemental regulatory application for Bondronat in Europe for treatment of metastatic bone disease in breast cancer patients more.. |
| Oct, 3 | Research Collaboration Agreement between New Chugai and Roche more.. |
| Oct, 1 | Roche - Chugai alliance successfully launched more.. |
| Sep, 23 | Roche and Kosan to jointly develop and commercialise Kosan's novel anti-cancer agent more.. |
| Sep, 17 | Regulatory filing for first HIV Fusion Inhibitor Fuzeon (T-20) more.. |
| Sep, 3 | Roche sells Vitamins and Fine Chemicals Division to DSM - Compelling strategic move for both companies more.. |
| Aug, 26 | Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes more.. |
| Aug, 14 | Roche Group with marked increase in operational profitability - Sales and profit projections for 2002 reaffirmed more.. |
| Aug, 14 | Half-Year Media Conference more.. |
| Jul, 30 | Roche licenses compounds to treat Alzheimer's disease from Memory Pharmaceuticals more.. |
| Jul, 16 | Xenical label change to incorporate new data on overweight and obese patients with type 2 diabetes granted by European Commission more.. |
| Jul, 5 | Zenapax use in pediatric renal transplant patients approved in Europe more.. |
| Jul, 1 | First human antibodies to reach Alzheimer's target more.. |
| Jun, 27 | Chugai shareholders approve Roche alliance with overwhelming majority more.. |
| Jun, 26 | Tamiflu marketing authorisation for treatment and prevention of influenza infection granted by European Commission more.. |
| Jun, 26 | Eleven further grants awarded to international scientists by the Roche Organ Transplantation Research Foundation more.. |
| Jun, 25 | Roche opens new production facility in South Africa more.. |
| Jun, 24 | Roche's presence in virology strengthened through drug development collaboration with Stressgen more.. |
| Jun, 19 | Targeting rheumatoid arthritis - New hope with smart drug Rituximab more.. |
| Jun, 7 | Roche Health Kiosk offers easy to understand information on complex health issues more.. |
| Jun, 6 | Roche and Genmab announce major expansion of antibody collaboration more.. |
| Jun, 6 | Roche Diagnostics acquires broad Human Papillomavirus (HPV) patent portfolio from the Institut Pasteur more.. |
| Jun, 4 | Roche to increase tender offer price for Chugai shareholders more.. |
| May, 23 | Roche given award for sponsoring medical care project in South Africa more.. |
| May, 16 | Positive Results from Second Phase III Study of HIV Fusion Inhibitor T-20 (enfuvirtide) more.. |
| May, 16 | Breakthrough approach to the management of amyloidosis more.. |
| May, 15 | Roche wins patent dispute with Chiron on Herceptin more.. |
| May, 14 | Roche and Vernalis announce new collaboration in depression and anxiety more.. |
| May, 8 | Amgen to acquire Filgrastim and Pegfilgrastim in Europe from Roche more.. |
| Apr, 25 | Roche R&D Day 2002: Innovation - our key to success more.. |
| Apr, 18 | Roche and Trimeris announce 24-week results from first Phase III study of HIV fusion inhibitor T-20 more.. |
| Apr, 16 | First-quarter sales growth at Roche in line with guidance more.. |
| Apr, 16 | 2002 Roche Annual General Meeting more.. |
| Apr, 16 | Roche Diagnostics comments on developments in Igen litigation more.. |
| Apr, 15 | New promising drug added to Roche's strong HIV Portfolio more.. |
| Apr, 9 | Roche publishes Group 10th safety and environmental protection report - S&E efforts paying off more.. |
| Apr, 9 | Strengthening of Roche's presence in transplantation medicine more.. |
| Mar, 26 | New biotech start-up formed under Roche leadership - BioXell: a new company in the field of immunology more.. |
| Mar, 25 | Two innovative cancer drugs approved in Europe more.. |
| Mar, 25 | Roche Licenses Synthetic Erythropoeisis Protein from Gryphon Sciences more.. |
| Mar, 21 | Triple success for Roche in Europe more.. |
| Mar, 21 | Roche and Speedel sign agreement on renin inhibitors more.. |
| Mar, 12 | Spring in the Garden of Eden - Roche brings the fascination of health to Expo.02 more.. |
| Mar, 7 | Roche prices the sale of LabCorp shares more.. |
| Feb, 27 | Roche's 2001 results show increased sales and operating profit, lower net income more.. |
| Feb, 27 | Annual Media Conference more.. |
| Feb, 16 | Roche Diagnostics announces judgement in Igen litigation more.. |
| Feb, 13 | Roche and Vernalis announce strategic alliance in diabetes more.. |
| Feb, 11 | Roche and Vernalis sign new research and development agreement on anti-obesity drugs more.. |
| Jan, 29 | Roche and deCODE unveil new alliance in drug discovery and development more.. |
| Jan, 25 | Making proteomics more efficient: Alliance between Roche and Bruker Daltonics to develop highly sensitive protein analysis more.. |
| Jan, 10 | Roche Diagnostics announces jury's decision in Igen litigation - Roche to file an appeal - Court still to decide on status of license more.. |
print this page